QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)

Stock Price Targets and Analyst Ratings

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Target Lowered byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.70
-1.6%
$26.00 ➝ $23.00Outperform ➝ Outperform
American Airlines Group Inc. stock logo
AAL
American Airlines Group
Target Lowered bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.70
-1.6%
$26.00 ➝ $23.00Outperform ➝ Outperform
Accenture plc stock logo
ACN
Accenture
Reiterated byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$310.63
-2.0%
$330.00Outperform ➝ Outperform
AdTheorent Holding Company, Inc. stock logo
ADTH
AdTheorent
Reiterated byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.17
-0.8%
$3.00Buy ➝ Buy
Aflac Incorporated stock logo
AFL
Aflac
Target Raised byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$76.44
-0.5%
$77.00 ➝ $83.00Outperform ➝ Outperform
AGCO Co. stock logo
AGCO
AGCO
Reiterated byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$115.52
-0.8%
$161.00Buy ➝ Buy
Apartment Income REIT Corp. stock logo
AIRC
Apartment Income REIT
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$30.65
-1.0%
$40.00 ➝ $33.00Buy ➝ Buy
AMC Entertainment Holdings, Inc. stock logo
AMC
AMC Entertainment
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.92
-2.8%
$15.50 ➝ $4.75Sell ➝ Sell
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Reiterated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$125.98
-4.0%
$174.00Buy ➝ Buy
Air Products and Chemicals, Inc. stock logo
APD
Air Products and Chemicals
Target Raised byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$286.77
-1.0%
$300.00 ➝ $310.00Hold ➝ Hold
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$43.18
+0.2%
$82.00Buy ➝ Buy
AppLovin Co. stock logo
APP
AppLovin
Target Raised byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$38.59
+1.0%
$40.00 ➝ $46.00Buy ➝ Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Burns
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.57
-3.7%
$28.00Buy ➝ Buy
AvalonBay Communities, Inc. stock logo
AVB
AvalonBay Communities
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$175.01
-1.5%
$190.00 ➝ $186.00Neutral ➝ Neutral
Aspira Women's Health Inc. stock logo
AWH
Aspira Women's Health
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.36
+4.9%
$4.00Neutral ➝ Neutral
AxoGen, Inc. stock logo
AXGN
AxoGen
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.68
-6.2%
$16.00Overweight ➝ Overweight
Bank of America Co. stock logo
BAC
Bank of America
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.16
-1.6%
$49.00 ➝ $48.00Outperform ➝ Outperform
Barclays PLC stock logo
BCS
Barclays
Upgraded byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.77
+2.0%
Equal Weight ➝ Overweight
Booking Holdings Inc. stock logo
BKNG
Booking
Reiterated byArgus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3,060.58
-1.2%
$3,677.00Buy ➝ Buy
Bumble Inc. stock logo
BMBL
Bumble
Initiated byHSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$14.79
-0.1%
$20.30Buy
Boston Properties, Inc. stock logo
BXP
Boston Properties
Initiated byCompass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$57.72
-3.2%
$65.00Neutral
Citigroup Inc. stock logo
C
Citigroup
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$40.22
-2.0%
$85.00 ➝ $81.00Outperform ➝ Outperform
CymaBay Therapeutics, Inc. stock logo
CBAY
CymaBay Therapeutics
Target Raised byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$14.83
+3.6%
$18.00 ➝ $25.00Buy ➝ Buy
CareDx, Inc stock logo
CDNA
CareDx
Reiterated byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.36
-3.7%
$10.00Equal Weight ➝ Equal Weight
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Target Raised byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$85.13
-0.9%
$95.00 ➝ $99.00Buy ➝ Buy
Coherus BioSciences, Inc. stock logo
CHRS
Coherus BioSciences
Reiterated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.98
-1.7%
$20.00Buy ➝ Buy
Coherus BioSciences, Inc. stock logo
CHRS
Coherus BioSciences
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.98
-1.7%
$20.00Buy ➝ Buy
Cingulate Inc. stock logo
CING
Cingulate
Target Lowered byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.71
+3.2%
$5.50 ➝ $3.50Buy ➝ Buy
Clarivate Plc stock logo
CLVT
Clarivate
Target Lowered byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.03
-2.1%
$10.00 ➝ $8.00Neutral ➝ Neutral
Comerica Incorporated stock logo
CMA
Comerica
Downgraded byOdeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.99
-3.5%
$46.00Buy ➝ Hold
Camden Property Trust stock logo
CPT
Camden Property Trust
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$96.44
-1.3%
$120.00 ➝ $101.00Buy ➝ Buy
Crescent Energy stock logo
CRGY
Crescent Energy
Initiated byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.21
-1.5%
Overweight
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Initiated byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$46.11
+0.5%
Buy
CrowdStrike Holdings, Inc. stock logo
CRWD
CrowdStrike
Reiterated byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.48
+0.4%
$235.00Market Outperform ➝ Market Outperform
Carlisle Companies Incorporated stock logo
CSL
Carlisle Companies
Downgraded byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$253.48
-0.9%
$325.00 ➝ $290.00Buy ➝ Hold
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
Target Lowered bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$36.78
-2.1%
$62.00 ➝ $61.00Outperform ➝ Outperform
DraftKings Inc. stock logo
DKNG
DraftKings
Upgraded byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.92
+2.0%
$26.00 ➝ $37.00Neutral ➝ Overweight
DraftKings Inc. stock logo
DKNG
DraftKings
Reiterated byBenchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.92
+2.0%
$37.00Buy ➝ Buy
Domino's Pizza, Inc. stock logo
DPZ
Domino's Pizza
Reiterated byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$379.22
-1.0%
$427.00 ➝ $450.00Outperform ➝ Outperform
DoubleVerify Holdings, Inc. stock logo
DV
DoubleVerify
Reiterated byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$27.40
-0.5%
$45.00Buy ➝ Buy
Elutia Inc. stock logo
ELUT
Elutia
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.25
+2.5%
$8.00Overweight ➝ Overweight
Equity Residential stock logo
EQR
Equity Residential
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$58.64
-1.1%
$68.00 ➝ $62.00Buy ➝ Buy
Essex Property Trust, Inc. stock logo
ESS
Essex Property Trust
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$213.69
-1.2%
$221.00 ➝ $219.00Neutral ➝ Neutral
Etsy, Inc. stock logo
ETSY
Etsy
Target Lowered byEvercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$61.87
-4.4%
$105.00 ➝ $85.00Outperform ➝ Outperform
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Upgraded byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$70.37
+1.3%
$90.00Market Perform ➝ Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
Initiated byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$21.75
-0.4%
$28.00Buy
Femasys Inc. stock logo
FEMY
Femasys
Target Raised byJonestrading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.48
+346.3%
$5.00 ➝ $7.00Buy ➝ Buy
Foot Locker, Inc. stock logo
FL
Foot Locker
Initiated byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$16.97
-2.7%
$19.00Neutral
Flowserve Co. stock logo
FLS
Flowserve
Upgraded byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$38.91
-0.8%
$40.00 ➝ $50.00Hold ➝ Buy
Fox Factory Holding Corp. stock logo
FOXF
Fox Factory
Reiterated byB. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Glaessgen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$94.99
-3.5%
$125.00Buy ➝ Buy
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
Downgraded byRobert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.39
+8.1%
Outperform ➝ Neutral
Fisker Inc. stock logo
FSR
Fisker
Initiated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$5.82
+9.6%
$8.00Buy ➝ Buy
General Dynamics Co. stock logo
GD
General Dynamics
Target Raised byBerenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$218.18
-0.5%
$254.00 ➝ $258.00Market Perform ➝ Market Perform
Glaukos Co. stock logo
GKOS
Glaukos
Reiterated byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$75.43
-1.2%
$90.00Buy ➝ Buy
Global-e Online Ltd. stock logo
GLBE
Global-e Online
Reiterated byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$37.39
-3.6%
$54.00Overweight ➝ Overweight
Genmab A/S stock logo
GMAB
Genmab A/S
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$36.53
+0.8%
$54.00Buy ➝ Buy
Granite Ridge Resources, Inc. stock logo
GRNT
Granite Ridge Resources
Initiated byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.02Overweight
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$323.67
-1.6%
$461.00 ➝ $450.00Outperform ➝ Outperform
Hudson Pacific Properties, Inc. stock logo
HPP
Hudson Pacific Properties
Upgraded byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.75
+2.0%
$11.00Neutral ➝ Buy
Hesai Group stock logo
HSAI
Hesai Group
Initiated byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$10.41
-1.0%
Buy
Intercept Pharmaceuticals, Inc. stock logo
ICPT
Intercept Pharmaceuticals
Downgraded byB. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$18.71
+79.2%
Buy ➝ Neutral
Immunovant, Inc. stock logo
IMVT
Immunovant
Upgraded byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.96
+97.0%
$40.00Market Perform ➝ Outperform
Immunovant, Inc. stock logo
IMVT
Immunovant
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.96
+97.0%
$30.00Buy ➝ Buy
Jamf Holding Corp. stock logo
JAMF
Jamf
Reiterated byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$17.17
-2.1%
$30.00Market Outperform ➝ Market Outperform
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$144.93
-1.0%
$219.00 ➝ $215.00Outperform ➝ Outperform
Nordstrom, Inc. stock logo
JWN
Nordstrom
Target Lowered byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$14.15
-1.2%
$14.00 ➝ $13.00Underperform ➝ Underperform
Korn Ferry stock logo
KFY
Korn Ferry
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$46.59
-1.3%
$65.00Buy ➝ Buy
Kohl's Co. stock logo
KSS
Kohl's
Target Lowered byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$19.82
-3.5%
$25.00 ➝ $22.00Underperform ➝ Underperform
Lazard Ltd stock logo
LAZ
Lazard
Target Lowered byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$30.34
-2.7%
$44.00 ➝ $42.00Overweight ➝ Overweight
Luminar Technologies, Inc. stock logo
LAZR
Luminar Technologies
Initiated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$4.01
-7.2%
Neutral ➝ Neutral
Liberty Latin America Ltd. stock logo
LILA
Liberty Latin America
Upgraded byScotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.89
-2.1%
Sector Perform
Open Lending Co. stock logo
LPRO
Open Lending
Reiterated byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$7.00
+0.6%
$11.00Market Outperform ➝ Market Outperform
Liquidia Co. stock logo
LQDA
Liquidia
Reiterated byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.31
+0.6%
$18.00Buy ➝ Buy
The Liberty SiriusXM Group stock logo
LSXMK
The Liberty SiriusXM Group
Target Raised byPivotal Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$23.65
+3.3%
$34.00 ➝ $41.00
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.48
+3.5%
$4.00Overweight ➝ Overweight
Southwest Airlines Co. stock logo
LUV
Southwest Airlines
Target Lowered bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$26.56
-3.4%
$32.00 ➝ $28.00Market Perform ➝ Market Perform
Las Vegas Sands Corp. stock logo
LVS
Las Vegas Sands
Target Lowered byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$45.28
-0.1%
$71.00 ➝ $64.00
Lyft, Inc. stock logo
LYFT
Lyft
Reiterated byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.92
+1.4%
Neutral
Mid-America Apartment Communities, Inc. stock logo
MAA
Mid-America Apartment Communities
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$130.49
+0.0%
$159.00 ➝ $133.00Neutral ➝ Neutral
MidWestOne Financial Group, Inc. stock logo
MOFG
MidWestOne Financial Group
Reiterated byStephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$19.33
-1.5%
$26.00Equal Weight ➝ Equal Weight
Morgan Stanley stock logo
MS
Morgan Stanley
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$82.17
-1.0%
$105.00 ➝ $100.00Outperform ➝ Outperform
Match Group, Inc. stock logo
MTCH
Match Group
Initiated byHSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$40.91
-1.4%
$47.10Hold
Vail Resorts, Inc. stock logo
MTN
Vail Resorts
Target Raised byJPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$237.94
-2.2%
$231.00 ➝ $280.00Neutral ➝ Neutral
Micron Technology, Inc. stock logo
MU
Micron Technology
Reiterated byRosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.94
-0.9%
$100.00Buy ➝ Buy
Micron Technology, Inc. stock logo
MU
Micron Technology
Target Raised byEvercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$67.94
-0.9%
$80.00 ➝ $90.00Outperform ➝ Outperform
Mainz Biomed stock logo
MYNZ
Mainz Biomed
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.15
-5.7%
$9.00Overweight ➝ Overweight
Nordson Co. stock logo
NDSN
Nordson
Downgraded byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$216.25
-3.6%
$260.00 ➝ $240.00Buy ➝ Hold
NIKE, Inc. stock logo
NKE
NIKE
Target Lowered byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$90.18
-0.5%
$128.00 ➝ $121.00Outperform ➝ Outperform
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.27
-0.9%
$30.00Overweight ➝ Overweight
Sunnova Energy International Inc. stock logo
NOVA
Sunnova Energy International
Target Lowered byThe Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$10.60
-3.2%
$17.00 ➝ $14.00Neutral ➝ Neutral
Nuvalent, Inc. stock logo
NUVL
Nuvalent
Initiated byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$42.08
-1.1%
Buy
O-I Glass, Inc. stock logo
OI
O-I Glass
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$16.95
-2.0%
$31.00Buy ➝ Buy
Olin Co. stock logo
OLN
Olin
Downgraded byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$45.95
-1.7%
$65.00 ➝ $50.00Overweight ➝ Equal Weight
Omnicell, Inc. stock logo
OMCL
Omnicell
Target Lowered byWells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$45.58
-6.0%
$56.00 ➝ $39.00Underweight ➝ Underweight
ProSomnus, Inc. stock logo
OSA
ProSomnus
Target Lowered byRoth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.94
-4.1%
$6.00 ➝ $4.00Buy ➝ Buy
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.23
-2.7%
$14.00Neutral ➝ Neutral
Paychex, Inc. stock logo
PAYX
Paychex
Reiterated byWedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$112.72
-1.4%
$115.00Neutral ➝ Neutral
Perion Network Ltd. stock logo
PERI
Perion Network
Reiterated byNeedham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$30.08
-0.1%
$42.00Buy ➝ Buy
Pinterest, Inc. stock logo
PINS
Pinterest
Initiated byHSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$25.91
-0.6%
$32.10Buy
Pinterest, Inc. stock logo
PINS
Pinterest
Initiated byJefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$25.91
-0.6%
$32.10Buy
PNM Resources, Inc. stock logo
PNM
PNM Resources
Upgraded byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$44.74
-0.1%
$50.30Neutral ➝ Buy
Perpetua Resources Corp. stock logo
PPTA
Perpetua Resources
Target Lowered byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.70
-2.9%
$10.25 ➝ $10.00Buy ➝ Buy
Prenetics Global Limited stock logo
PRE
Prenetics Global
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$0.45
-2.2%
$4.00Overweight ➝ Overweight
Qiagen stock logo
QGEN
Qiagen
Reiterated byCitigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.61
+1.2%
$60.00Buy ➝ Buy
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Osborn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.84
-0.8%
$26.00Overweight ➝ Overweight
Redfin Co. stock logo
RDFN
Redfin
Upgraded byGordon Haskett
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$6.88
-1.0%
$8.00 ➝ $7.00Underperform ➝ Hold
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
Reiterated byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.41
+21.5%
$23.00Buy ➝ Buy
Shopify Inc. stock logo
SHOP
Shopify
Reiterated byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Boone
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$51.50
-3.9%
$72.00Market Outperform ➝ Market Outperform
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$20.68
-2.5%
$30.00Overweight ➝ Overweight
Sirius XM Holdings Inc. stock logo
SIRI
Sirius XM
Target Lowered byPivotal Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$3.88
-3.2%
$5.00 ➝ $4.75
SiteOne Landscape Supply, Inc. stock logo
SITE
SiteOne Landscape Supply
Upgraded byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$160.32
+1.7%
$145.00 ➝ $200.00Neutral ➝ Buy
SL Green Realty Corp. stock logo
SLG
SL Green Realty
Initiated byCompass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$35.08
-4.1%
$27.00Sell
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Target Raised byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$26.80
+505.0%
$14.00 ➝ $39.00
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Target Raised byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Kluska
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$26.80
+505.0%
$19.00 ➝ $35.00Overweight ➝ Overweight
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$33.60
-0.7%
$59.00Overweight ➝ Overweight
SharkNinja, Inc. stock logo
SN
SharkNinja
Initiated byWilliam Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
43.00
+1.3%
Outperform
Snap Inc. stock logo
SNAP
Snap
Initiated byHSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$8.34
-3.0%
$7.50Reduce
SoundHound AI, Inc. stock logo
SOUN
SoundHound AI
Initiated byDA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$1.60
-8.6%
Buy
Splunk Inc. stock logo
SPLK
Splunk
Downgraded byBTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$145.65
+0.6%
Buy ➝ Neutral
Squarespace, Inc. stock logo
SQSP
Squarespace
Initiated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$28.22
-2.4%
Buy ➝ Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Reiterated byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$119.41
+4.1%
$160.00Buy ➝ Buy
Savers Value Village, Inc. stock logo
SVV
Savers Value Village
Reiterated byLoop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$19.17
-0.5%
$31.00Buy ➝ Buy
Teradyne, Inc. stock logo
TER
Teradyne
Upgraded byNorthland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$95.83
-0.6%
$126.00Market Perform ➝ Outperform
Target Co. stock logo
TGT
Target
Target Lowered byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$109.50
-2.5%
$145.00 ➝ $130.00Hold ➝ Hold
THOR Industries, Inc. stock logo
THO
THOR Industries
Target Raised byTruist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$92.86
-2.1%
$84.00 ➝ $86.00Hold ➝ Hold
THOR Industries, Inc. stock logo
THO
THOR Industries
Reiterated byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$92.86
-2.1%
$115.00Outperform ➝ Outperform
Tesla, Inc. stock logo
TSLA
Tesla
Reiterated byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$244.12
-1.2%
$305.00Outperform ➝ Outperform
Take-Two Interactive Software, Inc. stock logo
TTWO
Take-Two Interactive Software
Target Raised byUBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$137.38
-1.0%
$130.00 ➝ $151.00Neutral ➝ Neutral
United Airlines Holdings, Inc. stock logo
UAL
United Airlines
Target Lowered bySanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$42.65
-0.7%
$71.00 ➝ $69.00Outperform ➝ Outperform
UDR, Inc. stock logo
UDR
UDR
Target Lowered byMizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$35.71
-0.8%
$44.00 ➝ $38.00Neutral ➝ Neutral
U.S. Bancorp stock logo
USB
U.S. Bancorp
Target Lowered byOppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$33.01
-1.7%
$67.00 ➝ $62.00Outperform ➝ Outperform
Utz Brands, Inc. stock logo
UTZ
Utz Brands
Initiated byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$13.83
+2.0%
$17.00Outperform
Visteon Co. stock logo
VC
Visteon
Initiated byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$136.67
-1.6%
$180.00Buy ➝ Buy
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
Target Raised byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$15.83
+11.3%
$10.00 ➝ $25.00Buy ➝ Buy
Vornado Realty Trust stock logo
VNO
Vornado Realty Trust
Initiated byCompass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$21.61
-2.9%
$25.00Neutral
Workday, Inc. stock logo
WDAY
Workday
Reiterated byMorgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$229.24
-1.0%
$260.00Overweight ➝ Overweight
Wingstop Inc. stock logo
WING
Wingstop
Upgraded byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$176.79
+1.9%
$180.00 ➝ $200.00Hold ➝ Buy
Walmart Inc. stock logo
WMT
Walmart
Target Raised byStifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$162.54
-0.3%
$167.00 ➝ $169.00Hold ➝ Hold
W. P. Carey Inc. stock logo
WPC
W. P. Carey
Downgraded byBMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.60
-3.6%
$75.00 ➝ $60.00Outperform ➝ Market Perform
W. P. Carey Inc. stock logo
WPC
W. P. Carey
Target Lowered byBank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.60
-3.6%
$67.00 ➝ $54.00Underperform ➝ Underperform
W. P. Carey Inc. stock logo
WPC
W. P. Carey
Target Lowered byRoyal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$54.60
-3.6%
$79.00 ➝ $73.00Outperform ➝ Outperform
Whitestone REIT stock logo
WSR
Whitestone REIT
Reiterated byJMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$9.46
-2.1%
$13.00Market Outperform ➝ Market Outperform
Exagen Inc. stock logo
XGN
Exagen
Reiterated byCantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.38
+6.2%
$6.00Overweight ➝ Overweight

Always Get the Latest Stock Price Targets and Analyst Ratings: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Tuesday at 10:32 PM ET.

Key Points

  • Stock analysts give ratings to companies based on their research and insights.
  • Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
  • Analysts use different methodologies, so investors should always look into why a particular rating was given.
  • 5 stocks we like better than EXA)
Dice on financial graph: Are stock analyst ratings like rolling the dice? Find out.

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies. 

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings. 

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories." 

  • Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
  • Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOGUsing MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeatAnalysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance. 

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.  

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock? 

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.


Stock Ratings Reports and Tools

My Account -